Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

I know what you meant, but nothing has changed for Brilacidin in the past two years should ring alarm bells.

1. B-OM - Still no BP is willing to partner despite hiring Locust Walk twice. The BP who signed a term sheet backed out after doing DD.

2. B-ABSSSI - Still no partner despite positive Phase 2b result.

3. B-UP - Alfasigma is in no hurry advancing it.

By shifting shareholder's focus to COVID, Leo wasted another two years of B's patent life. The only thing changed is the total OS has doubled. Leo diluted shareholders from 212M shares in 11/2019 to 437M shares in 11/2021.

I'll repeat for those who's willing to listen. Not able to find a partner for B-ABSSSI and B-OM after all these years is a big red flag.

While I’m disappointed it didn’t help those suffering, I don’t think it changes much. At the end of the day, the original purpose and path for Brilacidin hasn’t really changed.